Hls Therapeutics Stock Price History
HLTRF Stock | USD 2.40 0.04 1.64% |
If you're considering investing in HLS Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of HLS Therapeutics stands at 2.40, as last reported on the 13th of December 2024, with the highest price reaching 2.40 and the lowest price hitting 2.40 during the day. At this point, HLS Therapeutics is very risky. HLS Therapeutics holds Efficiency (Sharpe) Ratio of 0.0298, which attests that the entity had a 0.0298% return per unit of volatility over the last 3 months. We have found twenty-seven technical indicators for HLS Therapeutics, which you can use to evaluate the volatility of the firm. Please check out HLS Therapeutics' risk adjusted performance of 0.0294, and Market Risk Adjusted Performance of 0.0844 to validate if the risk estimate we provide is consistent with the expected return of 0.11%.
HLS Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
HLS |
Sharpe Ratio = 0.0298
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | HLTRF | Huge Risk |
Negative Returns |
Estimated Market Risk
3.85 actual daily | 34 66% of assets are more volatile |
Expected Return
0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average HLS Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HLS Therapeutics by adding it to a well-diversified portfolio.
HLS Therapeutics Pink Sheet Price History Chart
There are several ways to analyze HLS Stock price data. The simplest method is using a basic HLS candlestick price chart, which shows HLS Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 17, 2024 | 2.84 |
Lowest Price | November 19, 2024 | 2.28 |
HLS Therapeutics December 13, 2024 Pink Sheet Price Synopsis
Various analyses of HLS Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell HLS Pink Sheet. It can be used to describe the percentage change in the price of HLS Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of HLS Pink Sheet.HLS Therapeutics Price Rate Of Daily Change | 0.98 | |
HLS Therapeutics Price Action Indicator | (0.02) |
HLS Therapeutics December 13, 2024 Pink Sheet Price Analysis
HLS Pink Sheet Price History Data
The price series of HLS Therapeutics for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 has a statistical range of 0.56 with a coefficient of variation of 6.05. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.55. The median price for the last 90 days is 2.6. The company completed dividends distribution on 2023-01-30.Open | High | Low | Close | Volume | ||
12/13/2024 | 2.40 | 2.40 | 2.40 | 2.40 | ||
12/12/2024 | 2.40 | 2.40 | 2.40 | 2.40 | 1.00 | |
12/11/2024 | 2.40 | 2.40 | 2.40 | 2.40 | 1.00 | |
12/10/2024 | 2.44 | 2.45 | 2.25 | 2.40 | 25,100 | |
12/09/2024 | 2.48 | 2.48 | 2.44 | 2.44 | 8,000 | |
12/06/2024 | 2.43 | 2.43 | 2.25 | 2.36 | 22,301 | |
12/05/2024 | 2.46 | 2.48 | 2.45 | 2.45 | 15,000 | |
12/04/2024 | 2.47 | 2.47 | 2.39 | 2.39 | 10,000 | |
12/03/2024 | 2.57 | 2.73 | 2.57 | 2.73 | 3,900 | |
12/02/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 1.00 | |
11/29/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 1.00 | |
11/28/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 100.00 | |
11/27/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 1.00 | |
11/26/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 100.00 | |
11/25/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 100.00 | |
11/22/2024 | 2.49 | 2.49 | 2.43 | 2.43 | 300.00 | |
11/21/2024 | 2.33 | 2.33 | 2.33 | 2.33 | 1.00 | |
11/20/2024 | 2.38 | 2.38 | 2.31 | 2.33 | 21,800 | |
11/19/2024 | 2.32 | 2.32 | 2.28 | 2.28 | 1,200 | |
11/18/2024 | 2.38 | 2.38 | 2.38 | 2.38 | 1.00 | |
11/15/2024 | 2.38 | 2.38 | 2.38 | 2.38 | 1.00 | |
11/14/2024 | 2.38 | 2.38 | 2.38 | 2.38 | 1.00 | |
11/13/2024 | 2.40 | 2.41 | 2.38 | 2.38 | 858.00 | |
11/12/2024 | 2.73 | 2.73 | 2.73 | 2.73 | 1.00 | |
11/11/2024 | 2.73 | 2.73 | 2.73 | 2.73 | 1.00 | |
11/08/2024 | 2.73 | 2.73 | 2.73 | 2.73 | 1,100 | |
11/07/2024 | 2.48 | 2.54 | 2.48 | 2.54 | 1,300 | |
11/06/2024 | 2.50 | 2.50 | 2.50 | 2.50 | 1.00 | |
11/05/2024 | 2.50 | 2.50 | 2.50 | 2.50 | 1.00 | |
11/04/2024 | 2.50 | 2.50 | 2.50 | 2.50 | 1.00 | |
11/01/2024 | 2.50 | 2.50 | 2.50 | 2.50 | 1.00 | |
10/31/2024 | 2.50 | 2.50 | 2.50 | 2.50 | 1.00 | |
10/30/2024 | 2.50 | 2.50 | 2.50 | 2.50 | 1.00 | |
10/29/2024 | 2.49 | 2.51 | 2.42 | 2.50 | 31,200 | |
10/28/2024 | 2.66 | 2.66 | 2.39 | 2.53 | 26,300 | |
10/25/2024 | 2.75 | 2.75 | 2.24 | 2.37 | 26,000 | |
10/24/2024 | 2.83 | 2.84 | 2.72 | 2.72 | 15,000 | |
10/23/2024 | 2.75 | 2.77 | 2.73 | 2.73 | 5,000 | |
10/22/2024 | 2.69 | 2.69 | 2.69 | 2.69 | 1.00 | |
10/21/2024 | 2.84 | 2.90 | 2.69 | 2.69 | 14,000 | |
10/18/2024 | 2.84 | 2.84 | 2.84 | 2.84 | 100.00 | |
10/17/2024 | 2.87 | 2.87 | 2.84 | 2.84 | 1,200 | |
10/16/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/15/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/14/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/11/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/10/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/09/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/08/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/07/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/04/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/03/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 300.00 | |
10/02/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
10/01/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
09/30/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
09/27/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 100.00 | |
09/26/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 1.00 | |
09/25/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 1.00 | |
09/24/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 1.00 | |
09/23/2024 | 2.60 | 2.60 | 2.60 | 2.60 | 200.00 | |
09/20/2024 | 2.34 | 2.34 | 2.34 | 2.34 | 300.00 |
About HLS Therapeutics Pink Sheet history
HLS Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HLS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HLS Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HLS Therapeutics stock prices may prove useful in developing a viable investing in HLS Therapeutics
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada. Hls Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 92 people.
HLS Therapeutics Pink Sheet Technical Analysis
HLS Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
All Next | Launch Module |
HLS Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for HLS Therapeutics' price direction in advance. Along with the technical and fundamental analysis of HLS Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of HLS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0294 | |||
Jensen Alpha | (0.02) | |||
Total Risk Alpha | (0.37) | |||
Sortino Ratio | 0.0014 | |||
Treynor Ratio | 0.0744 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for HLS Pink Sheet analysis
When running HLS Therapeutics' price analysis, check to measure HLS Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLS Therapeutics is operating at the current time. Most of HLS Therapeutics' value examination focuses on studying past and present price action to predict the probability of HLS Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLS Therapeutics' price. Additionally, you may evaluate how the addition of HLS Therapeutics to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |